INT242302

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.11
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 2.04
Pain Relevance 0.79

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

biosynthetic process (ACCS)
Anatomy Link Frequency
chest 2
ACCS (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 11 99.92 Very High Very High Very High
Angina 40 99.26 Very High Very High Very High
ischemia 4 64.24 Quite High
Bioavailability 2 57.16 Quite High
imagery 26 9.92 Low Low
Inflammation 5 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
metalloproteinase 1 5.00 Very Low Very Low Very Low
positron emission tomography 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Acute Coronary Syndrome 103 100.00 Very High Very High Very High
Pulmonary Embolism 10 99.92 Very High Very High Very High
Angina 39 99.26 Very High Very High Very High
Hemorrhage 17 99.18 Very High Very High Very High
Myocardial Infarction 18 78.88 Quite High
Coronary Artery Disease 27 64.24 Quite High
Emergencies 3 54.04 Quite High
Increased Venous Pressure Under Development 3 48.16 Quite Low
Renal Insufficiency 1 42.36 Quite Low
Disorder Of Lipid Metabolism 5 17.52 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In this exploratory, retrospective study, genotype, allele frequencies and stratified analysis of EGFR were compared between ACS cases and controls using the ?
Negative_regulation (compared) of Gene_expression (cases) of ACS associated with acute coronary syndrome
1) Confidence 0.11 Published 2008 Journal BMC Med Genet Section Body Doc Link PMC2515827 Disease Relevance 0.19 Pain Relevance 0
Two large randomized trials have compared bivalirudin to a combination of UFH and anti-GP IIb/IIIa inhibitors, and showed that efficacy was similar, with fewer bleeding events under bivalirudin therapy in the setting of NSTE-ACS,7 and a reduction in mortality in the setting of STEMI treated by primary angioplasty.8
Negative_regulation (reduction) of Gene_expression (setting) of NSTE-ACS associated with acute coronary syndrome and hemorrhage
2) Confidence 0.05 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2856573 Disease Relevance 0.41 Pain Relevance 0.03
Unfortunately, positive yield of this large number of admissions is as low as 2%–5%,4,5 and a majority of these patients (55%) are found to have noncardiac pathology.6 Conversely, 2% of patients with chest pain are discharged inappropriately with missed diagnosis of ACS, PE, and AD.6–8
Negative_regulation (missed) of Gene_expression (diagnosis) of ACS in chest associated with acute coronary syndrome, angina and cva
3) Confidence 0.02 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2879291 Disease Relevance 1.45 Pain Relevance 0.76

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox